COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,579 Articles (22,415 medRxiv, 8,164 bioRxiv)

Most recent first Previous |  Page 896: Articles 8951-8960  | Next

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 - January 2022
Stefanelli, P., Trentini, F., Petrone, D., Mammone, A., Ambrosio, L., Manica, M., Guzzetta, G., D Andrea, V., Marziano, V., Zardini, A., Molina Grane, C., Ajelli, M., Di Martino, A., Riccardo, F., Bella, A., Sane Schepisi, M., Maraglino, F., Poletti, P., Palamara, A. T., Brusaferro, S., Rezza, G., Pezzotti, P., Merler, S.
10.1101/2022.01.27.22269949 — Posted: 2022-01-29
A Machine Learning Approach to Differentiate Between COVID-19 and Influenza Infection Using Synthetic Infection and Immune Response Data
Farhang-Sardroodi, S., Ghaemi, M., Craig, M., Ooi, H. K., Heffernan, J. M.
10.1101/2022.01.27.22269978 — Posted: 2022-01-29
Hybrid immunity from SARS-CoV-2 delta variant surge induced low to undetectable levels of neutralizing antibodies against Omicron variant
Singh, J., Shaman, H., Singh, B., Anantharaj, A., Pargai, K., Chattopadhyay, P., Devi, P., Maurya, R., Mishra, P., Kahlon, N., Pandey, R., Pandey, A. K., Medigeshi, G. R.
10.1101/2022.01.28.22269990 — Posted: 2022-01-29
Performance of Various Lateral Flow SARS-CoV-2 Antigen Self Testing Methods in Healthcare Workers: a Multicenter Study.
Zwart, V. F., van der Moeren, N., Stohr, J. J. J. M., Feltkamp, M. C. W., Bentvelsen, R. G., Diederen, B. M. W., de Laat, A. C., Mascini, E. M., Schilders, I. G. P., Vlassak, H. T. M., Wertheim, H. F. L., Murk, J.-L. A. N., Kluytmans, J. A. J. W., van den Bijllaardt, W.
10.1101/2022.01.28.22269783 — Posted: 2022-01-29
Calprotectin and inflammation-associated serum biomarkers determine critical illness in COVID-19
Kassianides, G., Siampanos, A., Poulakou, G., Adamis, G., Rapti, A., MIlionis, H., Dalekos, G. N., Petrakis, V., Sympardi, S., Metallidis, S., Alexiou, Z., Gkavogianni, T., Giamarellos-Bourboulis, E., Theoharides, T. C.
10.1101/2022.01.28.22270001 — Posted: 2022-01-29
Agility and sustainability: A qualitative evaluation of COVID-19 Non-pharmaceutical Interventions (NPIs) in the UK logistics sector
Wei, H., Daniels, S. A., Whitfield, C. A., Han, Y., Denning, D. W., Hall, I., Regan, M., Verma, A., van Tongeren, M. J.
10.1101/2022.01.28.22270013 — Posted: 2022-01-29
COVID-19 self-testing in Nigeria: Stakeholders opinions and perspective on its value for case detection
Undelikwo, V. A., Shilton, S., Folayan, M. O., Alaba, O., Ivanova Reipold, E., Martinez-Perez, G.
10.1101/2022.01.28.22269743 — Posted: 2022-01-29
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Gangavarapu, K., Latiff, A. A., Mullen, J. L., Alkuzweny, M., Hufbauer, E., Tsueng, G., Haag, E., Zeller, M., Aceves, C. M., Zaiets, K., Cano, M., Zhou, J., Qian, Z., Sattler, R., Matteson, N. L., Levy, J. I., Suchard, M. A., Wu, C., Su, A. I., Andersen, K. G., Hughes, L. D.
10.1101/2022.01.27.22269965 — Posted: 2022-01-29
A mixed methods analysis of participation in social contact surveys
Nixon, E. J., Silvonen, T., Barreaux, A., Kwiatkowska, R., Trickey, A., Thomas, A. C., Ali, B., Treneman-evans, G., Christensen, H., Brooks Pollock, E., Denford, S.
10.1101/2022.01.28.22270006 — Posted: 2022-01-29
Comparative effectiveness of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
Lytras, T., Kontopidou, F., Lambrou, A., Tsiodras, S.
10.1101/2022.01.28.22270009 — Posted: 2022-01-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).